Key Points
-
Historically, conclusions of several systematic reviews and meta-analysis, based largely on low-quality evidence, suggest that medical expulsive therapy (MET) is effective in patients with ureteral stones
-
Data from two randomized controlled trials published in 2015 have challenged the previously well-accepted role of MET
-
Uncertainty currently exists on the exact role of MET in the management of patients with ureteral stones
-
MET might be beneficial for patients with distal ureteral stones >5 mm, although further research is required to confirm this suggestion
Abstract
Despite two decades of clinical use, the effectiveness of medical expulsive therapy (MET) for the noninvasive management of patients with ureteral stones has, in the past year, been called into in question. The primary aim of MET is to expedite stone passage, although it has also shown effectiveness in reducing time to stone passage, thus reducing the incidence of colic episodes, improving stone clearance and improving patients' quality of life. At least 11 systematic reviews and meta-analyses have been published showing clinical benefits of MET; however, the results of these analyses have been challenged by data from two randomized controlled, multicentre trials with large patient cohorts, thus providing higher quality evidence that MET is ineffective in patients with ureteral stones. Results of the various systematic reviews and meta-analyses have suggested that MET is effective, however, such analyses incorporate the biases and limitations of smaller cohort studies, resulting in their conclusions being based upon lower-quality evidence. Evidence for the use of MET for small (<5 mm) distal ureteral stones has weakened based on clinical trial data published in 2015. However, MET might remain effective in the management of larger ureteral stones (>5 mm).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Romero, V., Akpinar, H. & Assimos, D. G. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev. Urol. 12, e86–e96 (2010).
Ghani, K. R. et al. Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges. J. Urol. 191, 90–96 (2014).
Ghani, K. R. et al. Trends in surgery for upper urinary tract calculi in the USA using the Nationwide Inpatient Sample: 1999–2009. BJU Int. 112, 224–230 (2013).
Turk, C. et al. EAU Guidelines on Diagnosis and Conservative Management of Urolithiasis. Eur. Urol. 69, 475–482 (2016).
Pak, C. Y. Kidney stones. Lancet 351, 1797–1801 (1998).
De, S. K., Liu, X. & Monga, M. Changing trends in the American diet and the rising prevalence of kidney stones. Urology 84, 1030–1033 (2014).
Ziemba, J. B. & Matlaga, B. R. Guideline of guidelines: kidney stones. BJU Int. 116, 184–189 (2015).
Hollingsworth, J. M. et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 368, 1171–1179 (2006).
Singh, A., Alter, H. J. & Littlepage, A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann. Emerg. Med. 50, 552–563 (2007).
Seitz, C., Liatsikos, E., Porpiglia, F., Tiselius, H. G. & Zwergel, U. Medical therapy to facilitate the passage of stones: what is the evidence? Eur. Urol. 56, 455–471 (2009).
Davenport, K., Timoney, A. G. & Keeley, F. X. Jr . Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol. Res. 35, 207–213 (2007).
Miller, O. F. & Kane, C. J. Time to stone passage for observed ureteral calculi: a guide for patient education. J. Urol. 162, 688–690 (1999).
Coll, D. M., Varanelli, M. J. & Smith, R. C. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. AJR Am. J. Roentgenol. 178, 101–103 (2002).
Lamb, A. D., Vowler, S. L., Johnston, R., Dunn, N. & Wiseman, O. J. Meta-analysis showing the beneficial effect of alpha-blockers on ureteric stent discomfort. BJU Int. 108, 1894–1902 (2011).
Lu, Z. et al. Tamsulosin for ureteral stones: a systematic review and meta-analysis of a randomized controlled trial. Urol. Int. 89, 107–115 (2012).
Schuler, T. D., Shahani, R., Honey, R. J. & Pace, K. T. Medical expulsive therapy as an adjunct to improve shockwave lithotripsy outcomes: a systematic review and meta-analysis. J. Endourol. 23, 387–393 (2009).
Eryildirim, B. et al. Effect of medical expulsive therapy on the health-related quality of life of patients with ureteral stones: a critical evaluation. Int. Urol. Nephrol. 47, 1271–1275 (2015).
Loftus, C. et al. Medical expulsive therapy is underused for the management of renal colic in the emergency setting. J. Urol. 195, 987–991 (2016).
Lloyd, G., Lim, A., Hamoui, N., Nakada, S. Y. & Kielb, S. J. The use of medical expulsive therapy during pregnancy: a worldwide perspective. J. Endourol. 30, 354–358 (2016).
Zhou, L., Cai, X., Li, H. & Wang, K. J. Effects of α-blockers, antimuscarinics, or combination therapy in relieving ureteral stent-related symptoms: a meta-analysis. J. Endourol. 29, 650–656 (2015).
Velazquez, N. et al. Medical expulsive therapy for pediatric urolithiasis: systematic review and meta-analysis. J. Pediatr. Urol. 11, 321–327 (2015).
Bailey, G., Vaughan, L., Rose, C. & Krambeck, A. Perinatal outcomes with tamsulosin therapy for symptomatic urolithiasis. J. Urol. 195, 99–103 (2016).
Bos, D. & Kapoor, A. Update on medical expulsive therapy for distal ureteral stones: beyond α-blockers. Can. Urol. Assoc. J. 8, 442–445 (2014).
Borghi, L. et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J. Urol. 152, 1095–1098 (1994).
Huang, W., Xue, P., Zong, H. & Zhang, Y. Efficacy and safety of silodosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis. Br. J. Clin. Pharmacol. 81, 13–22 (2016).
Liu, C. et al. Efficacy and safety of alfuzosin as medical expulsive therapy for ureteral stones: a systematic review and meta-analysis. PLoS ONE 10, e0134589 (2015).
McClinton, S. et al. Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin): study protocol for a randomized controlled trial. Trials 15, 238 (2014).
Campschroer, T., Zhu, Y., Duijvesz, D., Grobbee, D. E. & Lock, M. T. α-blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst. Rev. 4, CD008509 (2014).
Skolarikos, A. et al. The efficacy of medical expulsive therapy (MET) in improving stone-free rate and stone expulsion time, after extracorporeal shock wave lithotripsy (SWL) for upper urinary stones: a systematic review and meta-analysis. Urology 86, 1057–1064 (2015).
Pickard, R. et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet 386, 341–349 (2015).
Furyk, J. S. et al. Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial. Ann. Emerg. Med. 67, 86–95.e2 (2015).
Assimos, D. et al. Surgical management of stones: American Urological Association/Endourological Society Guideline, PART II. J. Urol. http://dx.doi.org/10.1016/j.juro.2016.05.091 (2016).
Kronish, I. M. & Ye, S. Adherence to cardiovascular medications: lessons learned and future directions. Prog. Cardiovascu. Dis. 55, 590–600 (2013).
Egger, M. & Smith, G. D. Meta-analysis. potentials and promise. BMJ 315, 1371–1374 (1997).
Dechartres, A., Boutron, I., Trinquart, L., Charles, P. & Ravaud, P. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann. Intern. Med. 155, 39–51 (2011).
Edwards, P. J. et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst. Rev. 3, MR000008 (2014).
Akobeng, A. K. Understanding systematic reviews and meta-analysis. Arch. Dis. Child. 90, 845–848 (2005).
LeLorier, J., Gregoire, G., Benhaddad, A., Lapierre, J. & Derderian, F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N. Engl. J. Med. 337, 536–542 (1997).
Aldaqadossi, H. A., Shaker, H., Saifelnasr, M. & Gaber, M. Efficacy and safety of tamsulosin as a medical expulsive therapy for stones in children. Arab J. Urol. 13, 107–111 (2015).
Assimos, D. G. Re: medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. J. Urol. 194, 1313–1314 (2015).
Fan, B. et al. Can tamsulosin facilitate expulsion of ureteral stones? A meta-analysis of randomized controlled trials. Int. J. Urol. 20, 818–830 (2013).
Sahin, C. et al. Predictive parameters for medical expulsive therapy in ureteral stones: a critical evaluation. Urolithiasis 43, 271–275 (2015).
Assimos, D. et al. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J. Urol. http://dx.doi.org/10.1016/j.juro.2016.05.090 (2016).
Author information
Authors and Affiliations
Contributions
B.K.S. and O.A. researched data for this article, all authors made a substantial contribution to discussions of content, B.K.S. and O.A. wrote the manuscript, and all authors edited and/or reviewed the manuscript prior to submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Somani, B., Aboumarzouk, O., Traxer, O. et al. Medical expulsive therapy for ureteral stones: where do we go from here?. Nat Rev Urol 13, 608–612 (2016). https://doi.org/10.1038/nrurol.2016.146
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2016.146